Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process?
- 22 Downloads
PAF-acether (1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) is released from several cell sources simultaneously with an inactive non-acylated compound (1-O-alkyl-glyceryl-3-phosphorylcholine) (lyso-PAF-acether). Formation of the latter probably results from the activation of a phospholipase A2 (PLA2). Indeed, the PLA2 inhibitors, bromophenacyl bromide (BPB), mepacrine, 874CB (100 μM), and EDTA (5 mM), blocked the zymosan-induced release of PAF-acether from PC. EDTA and BPB also markedly reduced the release of lyso-PAF-acether. PAF-acether formation could involve a metabolic step linking the acetyl moiety to the 2nd carbon of lyso-PAF-acether. To verify this hypothesis, acetyl coenzyme A (acetyl-CoA) was added to stimulated PC. This enhanced the release of PAF-acether in a dose-dependent fashion from 1 μM acetyl-CoA to reach a maximal increase −200%—at 100 μM. Furthermore, using3H acetyl-CoA, incorporation of labelled acetate into PAF-acether was suggested by (1) identical chromatographic patterns of biological activity and radioactivity; (2) disappearance of these activities after treatment with PLA2, but not after exposure to lipase fromRhizopus arrhizus. PAF-acether was also obtained when both acetyl-CoA (100 μM) and synthetic lyso-PAF-acether (0.2 μM) were added to unstimulated PC previously treated with BPB (100 μM for 10 min). These results suggest that the release of PAF-acether is the consequence of at least two different steps: (1) hydrolysis of 1-O-alkyl-2-acyl-glyceryl-phosphorylcholine by PLA2; (2) enzymatic acetylation of the hydrolysis product.
KeywordsLipase Acetyl Hydrolysis Product Cell Source Mepacrine
Unable to display preview. Download preview PDF.
- J. Benveniste, C.G. Cochrane andP.M. Henson,Leukocyte-dependent histamine release from rabbit platelets: The role of IgE, basophils and a platelet-activating factor, J. Exp. Med.136, 1356–1377 (1972).Google Scholar
- J. Benveniste, M. Tence, P. Varenne, J. Bidault, C. Boullet andJ. Polonsky,Semi-synthèse et structure proposée du facteur activant les plaquettes (PAF): PAF-acéther, un alkyl éther analogue de la lysophosphatidylcholine, C.R. Acad. Sci. Paris289D, 1037–1040 (1979).Google Scholar
- J. Polonsky, M. Tence, P. Varenne, B.C. Das, J. Lunel andJ. Benveniste,Release of 1-O-alkyl-glyceryl-3-phosphorylcholine, O-deacetyl platelet-activating factor (lyso-PAF-acether) from leukocytes. Chemical ionization mass spectrometry of phospholipids, Proc. Natn. Acad. Sci. USA717, 1019–1028 (1980).Google Scholar
- J.M. Mencia-Huerta, C. Akerman andJ. Benveniste,Phospholipase A2 (PLA2), lipo (LO), cyclo (CO) oxygenases, and release of platelet-activating factor (PAF) and slow-reacting substance (SRS) from rat macrophages, Fedn Proc.39, 691 (Abs.) (1980).Google Scholar
- E. Ninio, J.M. Mencia-Huerta, F. Heymans andJ. Benveniste,Biosynthesis of platelet-activating factor (PAF-acether). I. Evidence for an acetyl transferase activity in murine macrophages, Biochim. Biophys. Acta, in press (1981).Google Scholar